Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/5F-SDB-006> ?p ?o }
Showing triples 1 to 60 of
60
with 100 triples per page.
- 5F-SDB-006 abstract "5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors. It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1". 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA.".
- 5F-SDB-006 iupacName "N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide".
- 5F-SDB-006 thumbnail 5F-SDB-006.png?width=300.
- 5F-SDB-006 wikiPageID "47064939".
- 5F-SDB-006 wikiPageLength "3659".
- 5F-SDB-006 wikiPageOutDegree "21".
- 5F-SDB-006 wikiPageRevisionID "678524822".
- 5F-SDB-006 wikiPageWikiLink 5F-CUMYL-PINACA.
- 5F-SDB-006 wikiPageWikiLink APICA.
- 5F-SDB-006 wikiPageWikiLink APICA_(synthetic_cannabinoid_drug).
- 5F-SDB-006 wikiPageWikiLink APINACA.
- 5F-SDB-006 wikiPageWikiLink Agonist.
- 5F-SDB-006 wikiPageWikiLink CUMYL-PICA.
- 5F-SDB-006 wikiPageWikiLink CUMYL-PINACA.
- 5F-SDB-006 wikiPageWikiLink CUMYL-THPINACA.
- 5F-SDB-006 wikiPageWikiLink Cannabinoid_receptor.
- 5F-SDB-006 wikiPageWikiLink Category:Cannabinoids.
- 5F-SDB-006 wikiPageWikiLink Category:Designer_drugs.
- 5F-SDB-006 wikiPageWikiLink Category:Indolecarboxamides.
- 5F-SDB-006 wikiPageWikiLink Category:Indoles.
- 5F-SDB-006 wikiPageWikiLink Federal_Analog_Act.
- 5F-SDB-006 wikiPageWikiLink Federal_Analogue_Act.
- 5F-SDB-006 wikiPageWikiLink SDB-006.
- 5F-SDB-006 wikiPageWikiLink STS-135_(drug).
- 5F-SDB-006 wikiPageWikiLink United_States.
- 5F-SDB-006 wikiPageWikiLink XLR-11_(drug).
- 5F-SDB-006 wikiPageWikiLinkText "5F-SDB-006".
- 5F-SDB-006 c "21".
- 5F-SDB-006 chemspiderid "30646773".
- 5F-SDB-006 f "1".
- 5F-SDB-006 h "23".
- 5F-SDB-006 hasPhotoCollection 5F-SDB-006.
- 5F-SDB-006 iupacName "N-benzyl-1--1H-indole-3-carboxamide".
- 5F-SDB-006 legalUs "possibly covered under the Federal Analogue Act in the United States and under similar bills in other countries".
- 5F-SDB-006 molecularWeight "338.43".
- 5F-SDB-006 n "2".
- 5F-SDB-006 o "1".
- 5F-SDB-006 smiles "FCCCCCn1ccCNCc1ccccc1".
- 5F-SDB-006 stdinchi "1".
- 5F-SDB-006 stdinchikey "VFLXAWVAWXHMFB-UHFFFAOYSA-N".
- 5F-SDB-006 wikiPageUsesTemplate Template:Cannabinoid-stub.
- 5F-SDB-006 wikiPageUsesTemplate Template:Cannabinoids.
- 5F-SDB-006 wikiPageUsesTemplate Template:Drugbox.
- 5F-SDB-006 subject Category:Cannabinoids.
- 5F-SDB-006 subject Category:Designer_drugs.
- 5F-SDB-006 subject Category:Indolecarboxamides.
- 5F-SDB-006 subject Category:Indoles.
- 5F-SDB-006 hypernym Drug.
- 5F-SDB-006 type ChemicalSubstance.
- 5F-SDB-006 type Drug.
- 5F-SDB-006 type ChemicalObject.
- 5F-SDB-006 type Thing.
- 5F-SDB-006 type Q8386.
- 5F-SDB-006 comment "5F-SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 of 50 nM for human CB1 receptors, and 123 nM for human CB2 receptors. It was discovered during research into the related compound APICA which had been sold illicitly as "2NE1". 5F-SDB-006 is the terminally fluorinated analog of SDB-006, just as STS-135 is the terminally fluorinated analog of APICA.".
- 5F-SDB-006 label "5F-SDB-006".
- 5F-SDB-006 sameAs Q20707158.
- 5F-SDB-006 sameAs Q20707158.
- 5F-SDB-006 wasDerivedFrom 5F-SDB-006?oldid=678524822.
- 5F-SDB-006 depiction 5F-SDB-006.png.
- 5F-SDB-006 isPrimaryTopicOf 5F-SDB-006.